PURPOSE: To assess the effect of changes in end-tidal partial pressure of O(2) (PETO(2)) on cerebrovascular reactivity (CVR) estimated from changes in blood oxygen level-dependent (BOLD) signal during cyclic changes in end-tidal partial pressure of CO(2) (PETCO(2)). MATERIALS AND METHODS: BOLD response to fixed cyclic step changes in PETCO(2) (range = 30.4-48.8 mmHg) and PETO(2) (range = 100.6-444.0 mmHg) was studied in four healthy volunteers. RESULTS: The BOLD reactivity to PETCO(2) and PETO(2) were 0.283 (0.188-0.379) (median, range) and 0.004 (0.003-0.006)%/mmHg, respectively, in the whole brain; 0.438 (0.382-0.614) vs. 0.006 (0.004-0.009)%/mmHg, respectively, in the gray matter; and 0.075 (0.065-0.093) vs. 0.002 (0.001-0.002)%/mmHg, respectively, in the white matter. CONCLUSION: The BOLD reactivity to PETO(2) was much smaller than that to PETCO(2). However, BOLD reactivity can be significantly distorted by CO(2)-induced changes in PETO(2). We conclude that PETO(2) should be carefully controlled during studies that use BOLD reactivity as an indicator of CVR.
PURPOSE: To assess the effect of changes in end-tidal partial pressure of O(2) (PETO(2)) on cerebrovascular reactivity (CVR) estimated from changes in blood oxygen level-dependent (BOLD) signal during cyclic changes in end-tidal partial pressure of CO(2) (PETCO(2)). MATERIALS AND METHODS: BOLD response to fixed cyclic step changes in PETCO(2) (range = 30.4-48.8 mmHg) and PETO(2) (range = 100.6-444.0 mmHg) was studied in four healthy volunteers. RESULTS: The BOLD reactivity to PETCO(2) and PETO(2) were 0.283 (0.188-0.379) (median, range) and 0.004 (0.003-0.006)%/mmHg, respectively, in the whole brain; 0.438 (0.382-0.614) vs. 0.006 (0.004-0.009)%/mmHg, respectively, in the gray matter; and 0.075 (0.065-0.093) vs. 0.002 (0.001-0.002)%/mmHg, respectively, in the white matter. CONCLUSION: The BOLD reactivity to PETO(2) was much smaller than that to PETCO(2). However, BOLD reactivity can be significantly distorted by CO(2)-induced changes in PETO(2). We conclude that PETO(2) should be carefully controlled during studies that use BOLD reactivity as an indicator of CVR.
Authors: Andrea S Doria; Adrian Crawley; Harpal Gahunia; Rahim Moineddin; Tammy Rayner; Vivian Tassos; Anguo Zhong; Kenneth Pritzker; Maria Mendes; Roland Jong; Robert B Salter Journal: Pediatr Radiol Date: 2011-08-05
Authors: Ali M Golestani; Jonathan B Kwinta; Stephen C Strother; Yasha B Khatamian; J Jean Chen Journal: Neuroimage Date: 2016-02-23 Impact factor: 6.556
Authors: Alexandra Mardimae; Dahlia Y Balaban; Matthew A Machina; Anne Battisti-Charbonney; Jay S Han; Rita Katznelson; Leonid L Minkovich; Ludwik Fedorko; Patricia M Murphy; Marcin Wasowicz; Finola Naughton; Massimiliano Meineri; Joseph A Fisher; James Duffin Journal: Pflugers Arch Date: 2012-09-09 Impact factor: 3.657
Authors: Shoji Ito; Alexandra Mardimae; Jay Han; James Duffin; Greg Wells; Ludwik Fedorko; Leonid Minkovich; Rita Katznelson; Massimiliano Meineri; Tamara Arenovich; Cathie Kessler; Joseph A Fisher Journal: J Physiol Date: 2008-06-19 Impact factor: 5.182
Authors: K R Thulborn; I C Atkinson; A Alexander; M Singal; S Amin-Hanjani; X Du; A Alaraj; F T Charbel Journal: AJNR Am J Neuroradiol Date: 2018-01-25 Impact factor: 3.825
Authors: Amir Iranmahboob; Kyung K Peck; Nicole P Brennan; Sasan Karimi; Ryan Fisicaro; Bob Hou; Andrei I Holodny Journal: J Neuroimaging Date: 2016 Mar-Apr Impact factor: 2.486
Authors: Nicholas P Blockley; Valerie E M Griffeth; Michael A Germuska; Daniel P Bulte; Richard B Buxton Journal: Neuroimage Date: 2013-01-28 Impact factor: 6.556